Literature DB >> 26851521

Simple and reliable genotyping protocol for mouse Prkdc(SCID) mutation.

Rolen M Quadros1, Larisa Y Poluektova2, Channabasavaiah B Gurumurthy3.   

Abstract

Mutant mouse models, genetically-engineered or spontaneous-mutations, serve as valuable tools for biomedical research. Genotyping of mutant mice is a critical requirement for maintaining the colony, to breed with other mutants and to match the phenotypic observations. The SCID (Severe Combine Immuno Deficiency) mouse model has been extensively used as a common background-strain in many immunology and transplantation studies. Many different types of assays, including Restriction Fragment Length Polymorphism (RFLP), confronting two primer pairs PCR and end-point methods have been attempted for establishing a genotyping protocol for the SCID mutation. However, the best method that is thought to be reliable is sequencing, which requires additional time and resources to perform on a routine basis. In this report, we describe a novel RFLP assay that is simple and reliable. The method is validated by sequencing analysis, and this novel method can be adapted for routine genotyping of SCID model.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Genotyping; Humanized mice; NSG; RFLP; SCID

Mesh:

Substances:

Year:  2016        PMID: 26851521      PMCID: PMC4818111          DOI: 10.1016/j.jim.2016.02.002

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  8 in total

1.  Cause and solutions to the polymerase chain reaction smear problem in genotyping.

Authors:  Dawn D Han; Rong Chen; Erik R Hill; Michael R Tilley; Howard H Gu
Journal:  Anal Biochem       Date:  2006-04-07       Impact factor: 3.365

2.  Reproducibility: use mouse biobanks or lose them.

Authors:  Kent Lloyd; Craig Franklin; Cat Lutz; Terry Magnuson
Journal:  Nature       Date:  2015-06-11       Impact factor: 49.962

3.  Molecular genotyping of the mouse scid allele.

Authors:  Amy L Sealey; Nicole K Hobbs; Edward E Schmidt
Journal:  J Immunol Methods       Date:  2002-02-01       Impact factor: 2.303

4.  Identification of a nonsense mutation in the carboxyl-terminal region of DNA-dependent protein kinase catalytic subunit in the scid mouse.

Authors:  T Blunt; D Gell; M Fox; G E Taccioli; A R Lehmann; S P Jackson; P A Jeggo
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

5.  Genotyping the mouse severe combined immunodeficiency mutation using the polymerase chain reaction with confronting two-pair primers (PCR-CTPP).

Authors:  Chika Maruyama; Hiroshi Suemizu; Shojiro Tamamushi; Shigenobu Kimoto; Norikazu Tamaoki; Yasuyuki Ohnishi
Journal:  Exp Anim       Date:  2002-07

6.  A severe combined immunodeficiency mutation in the mouse.

Authors:  G C Bosma; R P Custer; M J Bosma
Journal:  Nature       Date:  1983-02-10       Impact factor: 49.962

7.  ZyFISH: a simple, rapid and reliable zygosity assay for transgenic mice.

Authors:  Donal McHugh; Tracy O'Connor; Juliane Bremer; Adriano Aguzzi
Journal:  PLoS One       Date:  2012-05-29       Impact factor: 3.240

8.  Development and function of human innate immune cells in a humanized mouse model.

Authors:  Anthony Rongvaux; Tim Willinger; Jan Martinek; Till Strowig; Sofia V Gearty; Lino L Teichmann; Yasuyuki Saito; Florentina Marches; Stephanie Halene; A Karolina Palucka; Markus G Manz; Richard A Flavell
Journal:  Nat Biotechnol       Date:  2014-03-16       Impact factor: 54.908

  8 in total
  1 in total

1.  Antiretroviral Drug Metabolism in Humanized PXR-CAR-CYP3A-NOG Mice.

Authors:  JoEllyn M McMillan; Denise A Cobb; Zhiyi Lin; Mary G Banoub; Raghubendra S Dagur; Amanda A Branch Woods; Weimin Wang; Edward Makarov; Ted Kocher; Poonam S Joshi; Rolen M Quadros; Donald W Harms; Samuel M Cohen; Howard E Gendelman; Channabasavaiah B Gurumurthy; Santhi Gorantla; Larisa Y Poluektova
Journal:  J Pharmacol Exp Ther       Date:  2018-02-23       Impact factor: 4.030

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.